Content of invitations for publicly funded screening mammography

British Medical Journal

Volumn 332, Issue 7540, 2006, Pages 538-541

  Jørgensen, Karsten Juhl ^a   Gøtzsche, Peter C ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER SCREENING; DECISION MAKING; HEALTH SURVEY; HUMAN; INFORMED CONSENT; MAMMOGRAPHY; MEDICAL EDUCATION; MEDICAL PRACTICE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SCANDINAVIA; ARTICLE; ATTITUDE TO HEALTH; BREAST TUMOR; CLINICAL TRIAL; FEMALE; HOSPITAL MANAGEMENT; INTERPERSONAL COMMUNICATION; MASS SCREENING; MULTICENTER STUDY; PATIENT ATTITUDE; PATIENT EDUCATION; PROFESSIONAL PRACTICE; PUBLICATION; STANDARD; STATISTICS; UTILIZATION REVIEW;

APPOINTMENTS AND SCHEDULES; ATTITUDE TO HEALTH; BREAST NEOPLASMS; COMMUNICATION; FEMALE; HUMANS; INFORMED CONSENT; MAMMOGRAPHY; MASS SCREENING; PAMPHLETS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; PROFESSIONAL PRACTICE;

EID: 33644890169     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.332.7540.538     Document Type: Review

References (24)

1. Slaytor EK, Ward JE. How risks of breast cancer and benefits of screening are communicated to women: analysis of 58 pamphlets. BMJ 1998;317:263-4.
2. Jørgensen KJ, Gøtzsche PC. Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study. BMJ 2004;328:148.
3. Vainio H, Bianchini F. IARC handbooks of cancer prevention. Vol 7: breast cancer screening. Lyons: IARC Press, 2002.
4. Domenighetti G, D'Avanzo B, Egger M, Berrino F, Perneger T, Mosconi P, et al. Women's perception of the benefits of mammography screening: population-based survey in four countries. Int Epidemiol 2003;32:816-21.
5. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG. Enthusiasm for cancer screening in the United States. JAMA 2004;291:71-8.
6. Barratt AL, Cockburn J, Redman S, Paul C, Perkins J. Mammographic screening: results from the 1996 national breast health survey. Med J Aust 1997;167:521-4.
7. Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993;341:973-8.
8. Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-2. http://image.thelancet. com/extras/fullreport.pdf (accessed 8 Feb 2006).
9. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;137:347-60.
10. Kösters JP, Gøtzsche PC. Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev 2003;(2):CD003373.
11. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998;338:1089-96.
12. Smith-Bindman R, Chu PW, Miglioretti DL, Sickles EA, Blanks R, Ballard-Barbash R, et al. Comparison of screening mammography in the United States and the United Kingdom. JAMA 2003;290:2129-37.
13. Aro AR, Pilvikki Absetz S, van Elderen TM, van der Ploeg E, van der Kamp LJ. False-positive Findings in mammography screening induces short-term distress-breast cancer-specioc concern prevails longer. Eur J Cancer 2000;36:1089-97.
14. Fahey T, Griffiths S, Peters TJ. Evidence based purchasing: understanding results of clinical trials and systematic reviews. BMJ 1995;311:1056-9.
15. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-19.
16. Gøtzsche PC. On the benefits and harms of screening for breast cancer. Int J Epidemiol 2004;33:56-64.
17. Zahl PH, Strand BH, Mæhlen J. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 2004;328:921-4.
18. Douek M, Baum M. Mass breast screening: Is there a hidden cost? Br J Surg 2003;90:44-5.
19. Barratt A, Howard K, Irwig L, Salkeld G, Houssami N. Model of outcomes of screening mammography: information to support informed choices. BMJ 2005;330:936-8.
20. Jonsson H, Johansson R, Lenner P. Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer 2005;117:842-7.
21. Welch HG, Black WC. Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med 1997;127:1023-8.
22. Welch HG. Should I be tested for cancer? Maybe not and here's why. Los Angeles: University of California Press, 2004.
23. Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG. US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ 2000;320:1635-40.
24. Bonfill X, Marzo M, Pladevall M, Marti J, Emparanza JI. Strategies for increasing women participation in community breast cancer screening. Cochrane Database Syst Rev 2001;(1):CD002943.